1 Study Coverage

• 1.1 Varicella Vaccination Product Introduction
• 1.2 Global Varicella Vaccination Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Varicella Vaccination Sales in US$ Million for the Year 2017-2028

1.2.2 Global Varicella Vaccination Sales in Volume for the Year 2017-2028

1.3 United States Varicella Vaccination Outlook 2017 VS 2022 VS 2028

1.3.1 United States Varicella Vaccination Sales in US$ Million for the Year 2017-2028

1.3.2 United States Varicella Vaccination Sales in Volume for the Year 2017-2028

1.4 Varicella Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Varicella Vaccination in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Varicella Vaccination Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Varicella Vaccination Market Dynamics

1.5.1 Varicella Vaccination Industry Trends

1.5.2 Varicella Vaccination Market Drivers

1.5.3 Varicella Vaccination Market Challenges

1.5.4 Varicella Vaccination Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Type

• 2.1 Varicella Vaccination Market Segment by Type
• 2.1.1 Monovalent Vaccine

2.1.2 Combination Vaccine

2.2 Global Varicella Vaccination Market Size by Type

2.2.1 Global Varicella Vaccination Sales in Value, by Type (2017, 2022 & 2028)

2.2.2 Global Varicella Vaccination Sales in Volume, by Type (2017, 2022 & 2028)

2.2.3 Global Varicella Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

2.3 United States Varicella Vaccination Market Size by Type

2.3.1 United States Varicella Vaccination Sales in Value, by Type (2017, 2022 & 2028)

2.3.2 United States Varicella Vaccination Sales in Volume, by Type (2017, 2022 & 2028)

2.3.3 United States Varicella Vaccination Average Selling Price (ASP) by Type (2017, 2022 & 2028)

3 Market by Application

• 3.1 Varicella Vaccination Market Segment by Application
• 3.1.1 Children

3.1.2 Adults

3.2 Global Varicella Vaccination Market Size by Application

3.2.1 Global Varicella Vaccination Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Varicella Vaccination Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Varicella Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Varicella Vaccination Market Size by Application

3.3.1 United States Varicella Vaccination Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Varicella Vaccination Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Varicella Vaccination Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Varicella Vaccination Competitor Landscape by Company

• 4.1 Global Varicella Vaccination Market Size by Company
• 4.1.1 Top Global Varicella Vaccination Manufacturers Ranked by Revenue (2021)

4.1.2 Global Varicella Vaccination Revenue by Manufacturer (2017-2022)

4.1.3 Global Varicella Vaccination Sales by Manufacturer (2017-2022)

4.1.4 Global Varicella Vaccination Price by Manufacturer (2017-2022)

4.2 Global Varicella Vaccination Concentration Ratio (CR)

4.2.1 Varicella Vaccination Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Varicella Vaccination in 2021

4.2.3 Global Varicella Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Varicella Vaccination Manufacturing Base Distribution, Product Type

4.3.1 Global Varicella Vaccination Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Varicella Vaccination Product Type

4.3.3 Date of International Manufacturers Enter into Varicella Vaccination Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Varicella Vaccination Market Size by Company

4.5.1 Top Varicella Vaccination Players in United States, Ranked by Revenue (2021)

4.5.2 United States Varicella Vaccination Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Varicella Vaccination Sales by Players (2020, 2021 & 2022)

5 Global Varicella Vaccination Market Size by Region

• 5.1 Global Varicella Vaccination Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Varicella Vaccination Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Varicella Vaccination Sales in Volume by Region: 2017-2022

5.2.2 Global Varicella Vaccination Sales in Volume Forecast by Region (2023-2028)

5.3 Global Varicella Vaccination Market Size in Value by Region (2017-2028)

5.3.1 Global Varicella Vaccination Sales in Value by Region: 2017-2022

5.3.2 Global Varicella Vaccination Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Varicella Vaccination Market Size YoY Growth 2017-2028

6.1.2 North America Varicella Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Varicella Vaccination Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Varicella Vaccination Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Varicella Vaccination Market Size YoY Growth 2017-2028

6.3.2 Europe Varicella Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Varicella Vaccination Market Size YoY Growth 2017-2028

6.4.2 Latin America Varicella Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Varicella Vaccination Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Varicella Vaccination Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Merck
• 7.1.1 Merck Corporation Information

7.1.2 Merck Description and Business Overview

7.1.3 Merck Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.1.4 Merck Varicella Vaccination Products Offered

7.1.5 Merck Recent Development

7.2 BCHT

7.2.1 BCHT Corporation Information

7.2.2 BCHT Description and Business Overview

7.2.3 BCHT Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.2.4 BCHT Varicella Vaccination Products Offered

7.2.5 BCHT Recent Development

7.3 Shanghai Institute

7.3.1 Shanghai Institute Corporation Information

7.3.2 Shanghai Institute Description and Business Overview

7.3.3 Shanghai Institute Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.3.4 Shanghai Institute Varicella Vaccination Products Offered

7.3.5 Shanghai Institute Recent Development

7.4 GSK

7.4.1 GSK Corporation Information

7.4.2 GSK Description and Business Overview

7.4.3 GSK Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.4.4 GSK Varicella Vaccination Products Offered

7.4.5 GSK Recent Development

7.5 Keygen

7.5.1 Keygen Corporation Information

7.5.2 Keygen Description and Business Overview

7.5.3 Keygen Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.5.4 Keygen Varicella Vaccination Products Offered

7.5.5 Keygen Recent Development

7.6 Green Cross

7.6.1 Green Cross Corporation Information

7.6.2 Green Cross Description and Business Overview

7.6.3 Green Cross Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.6.4 Green Cross Varicella Vaccination Products Offered

7.6.5 Green Cross Recent Development

7.7 Biken

7.7.1 Biken Corporation Information

7.7.2 Biken Description and Business Overview

7.7.3 Biken Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.7.4 Biken Varicella Vaccination Products Offered

7.7.5 Biken Recent Development

7.8 Shanghai Rongsheng Biotech

7.8.1 Shanghai Rongsheng Biotech Corporation Information

7.8.2 Shanghai Rongsheng Biotech Description and Business Overview

7.8.3 Shanghai Rongsheng Biotech Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.8.4 Shanghai Rongsheng Biotech Varicella Vaccination Products Offered

7.8.5 Shanghai Rongsheng Biotech Recent Development

7.9 Changsheng

7.9.1 Changsheng Corporation Information

7.9.2 Changsheng Description and Business Overview

7.9.3 Changsheng Varicella Vaccination Sales, Revenue and Gross Margin (2017-2022)

7.9.4 Changsheng Varicella Vaccination Products Offered

7.9.5 Changsheng Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Varicella Vaccination Industry Chain Analysis
• 8.2 Varicella Vaccination Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Varicella Vaccination Distributors

8.3 Varicella Vaccination Production Mode & Process

8.4 Varicella Vaccination Sales and Marketing

8.4.1 Varicella Vaccination Sales Channels

8.4.2 Varicella Vaccination Distributors

8.5 Varicella Vaccination Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Market Analysis and Insights: Global and United States Varicella Vaccination Market

This report focuses on global and United States Varicella Vaccination market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Varicella Vaccination market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Monovalent Vaccine accounting for % of the Varicella Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Children was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Varicella Vaccination market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Varicella Vaccination Scope and Market Size

Varicella Vaccination market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Varicella Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Varicella Vaccination market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Varicella Vaccination market is segmented into

Monovalent Vaccine

Combination Vaccine

Segment by Application, the Varicella Vaccination market is segmented into

Children

Adults

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Varicella Vaccination Market Share Analysis

Varicella Vaccination market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Varicella Vaccination business, the date to enter into the Varicella Vaccination market, Varicella Vaccination product introduction, recent developments, etc.

The major vendors covered:

Merck

BCHT

Shanghai Institute

GSK

Keygen

Green Cross

Biken

Shanghai Rongsheng Biotech

Changsheng